In non-small cell lung cancer (NSCLC), patients with increased numbers of Meflin-positive CAFs exhibited greater tumor vessel areas and higher numbers of infiltrating CD4+ T cells in the stroma [152]. This evidence concerns the gene ISLR and non-small cell lung carcinoma.